Our Portfolio

Gryphon Investors V

Key stats
Commitment date April 2019
Region North America
Strategy Mid-market buyours
Focus Business services, consumer, healthcare and industrial growth
Fund size $2.1bn


Gryphon Investors is a long-established US manager based in San Francisco focused on business services, consumer, healthcare and industrial growth. We invested in its fifth fund, which by the time of its final close was already over half invested. This allows us to diligence the underlying investments, as well as to deploy capital more efficiently. Gryphon has a highly focused, thematic origination approach which seeks to identify companies within tightly defined sub-sectors which have characteristics aligned with our defensive growth focus. Shortly after committing to the fund, we co-invested in a Gryphon V investment, RegEd.

Investment Rationale

  • Experienced senior team with deep experience through market cycles
  • Strong and consistent track record
  • High degree of strategic alignment with ICG Enterprise
  • Focus on ‘defensive growth’ assets
  • Late stage primary

More case studies

Share price (ICGT)

-14.00P (-1.30%)
9:52PM 1 Jul 2022
The share price information is delayed by at least 15 minutes

NAV per share

As of 30 April 2022
Full year results for the twelve months ended 31 January 2022
Year Net assets NAV per share Share price Dividends per share
Jan 2022 £1,158m 1,690p 1,200p 27p
Jan 2021 £952m 1,384p 966p 24p
Jan 2020 £794m 1,152p 966p 23p
Jan 2019 £731m 1,057p 822p 22p
Jan 2018 £664m 959p 818p 21p
Jan 2017 £613m 871p 698p 20p
Jan 2016 £521m 731p 545p 11p
Jan 2015 £507m 695p 575p 15.5p
Jan 2014 £494m 677p 563p 15.5p
Jan 2013 £460m 631p 487p 5p
Jan 2012 £415m 569p 357p 5p
Jan 2011 £389m 534p 308p 2.25p
Dec 2009 £338m 464p 305p 2.25p
Dec 2008 £327m 449p 187p 4.5p